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The mitochondrial electron transport system (ETS) is responsible for setting and
maintaining both the energy and redox charges throughout the cell. Reversible
phosphorylation of mitochondrial proteins, particularly via the soluble adenylyl cyclase
(sAC)/cyclic AMP (cAMP)/Protein kinase A (PKA) axis, has recently been revealed as
a potential mechanism regulating the ETS. However, the governance of cAMP/PKA
signaling and its implications on ETS function are incompletely understood. In contrast
to prior reports using exogenous bicarbonate, we provide evidence that endogenous
CO2 produced by increased tricarboxylic acid (TCA) cycle flux is insufficient to increase
mitochondrial cAMP levels, and that exogenous addition of membrane permeant
8Br-cAMP does not enhance mitochondrial respiratory capacity. We also report
important non-specific effects of commonly used inhibitors of sAC which preclude their
use in studies of mitochondrial function. In isolated liver mitochondria, inhibition of PKA
reduced complex I-, but not complex II-supported respiratory capacity. In permeabilized
myofibers, inhibition of PKA lowered both the Km and Vmax for complex I-supported
respiration as well as succinate-supported H2O2 emitting potential. In summary, the
data provided here improve our understanding of how mitochondrial cAMP production
is regulated, illustrate a need for better tools to examine the impact of sAC activity
on mitochondrial biology, and suggest that cAMP/PKA signaling contributes to the
governance of electron flow through complex I of the ETS.
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INTRODUCTION
Mitochondrial function is a key determinant of skeletal muscle metabolic health since it
governs both the energetic and redox environments of the myocyte. Under conditions of
overnutrition and/or obesity, evidence suggests mitochondria from humans and rodents
increase their rate of hydrogen peroxide (H2O2) emission (Houstis et al., 2006; Fisher-
Wellman et al., 2014), with the resulting increase in oxidative burden impairing skeletal
muscle insulin action (Anderson et al., 2009; Hoehn et al., 2009; Lark et al., 2015). Key
enzymes within the electron transport system and the matrix regulate the rate of H2O2
production and scavenging that ultimately determine the rate of H2O2 release. Therefore,
a better understanding of how mitochondrial enzymes are regulated may lead to better
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treatments for diseases like diabetes that are linked to
mitochondrial H2O2 emission.
Mounting evidence implicates post-translational
modifications to mitochondrial proteins, particularly
phosphorylation events mediated by the cyclic adenosine
monophosphate (cAMP)/Protein kinase A (PKA) axis, as a
key regulator of cellular metabolism (Valsecchi et al., 2013; Di
Benedetto et al., 2014). Mitochondrial cAMP/PKA signaling is
thought to be initiated by soluble adenylyl cyclase (sAC) (Buck
et al., 1999), a bicarbonate (HCO−3 )- and Ca
2+-activated (Chen
et al., 2000) enzyme that generates cAMP in various intracellular
compartments (e.g., mitochondrial matrix) (Zippin et al., 2003).
The implication is that CO2 generated during accelerated flux
through the tricarboxylic acid (TCA) cycle is converted to HCO−3
via carbonic anhydrase (CA) and activates the mitochondrial
cAMP/PKA axis. However, although it is well-established that
exogenous HCO−3 can activate mitochondrial sAC (Chen et al.,
2000; Zippin et al., 2003), it is not known whether increased
endogenous metabolic CO2 production increases mitochondrial
cAMP.
Analysis of the MitoCarta mitochondrial proteome database
(Pagliarini et al., 2008) has revealed approximately 75 different
putative targets of PKA-mediated phosphorylation, some of
which are altered by dietary manipulation (Grimsrud et al.,
2012). Available evidence suggests cAMP/PKA signaling alters
oxidative phosphorylation (OXPHOS) by regulating cytochrome
C oxidase (Acin-Perez et al., 2009a,b, 2010) or enhancing
ATP production in the presence of Ca2+ (Di Benedetto et al.,
2013). Additionally, several independent groups have identified
Complex I of the electron transport system (ETS) as a target of
PKA-dependent phosphorylation (Papa, 2002; De Rasmo et al.,
2010) with a potential role in a number of human pathologies
(Valenti et al., 2011; Papa et al., 2012). Despite the cummulative
evidence implicating cAMP/PKA-mediated regulation of the ETS
in human disease, the potential functional impact of cAMP/PKA-
mediated phosphorylation on mitochondrial bioenergetics is not
well understood.
Therefore, the purpose of the present study was to
determine: (1) if endogenous CO2 production from the TCA
cycle is sufficient to increase mitochondrial cAMP levels and (2)
whether PKA acts on multiple ETS complexes (including
Complex I) as a feed-forward mechanism to enhance OXPHOS
in response to metabolic demand.
METHODS
Chemicals and Reagents
All chemicals and reagents were obtained from Sigma Aldrich
except for Amplex Ultra Red reagent, which was purchased from
Molecular Probes Inc.
Animal Use Procedures
All aspects of rodent studies were approved by the East Carolina
University Animal Care and Use Committee. Male C57BL6/NJ
mice were purchased from Jackson Laboratories and were the
only model used in these studies. Mice were housed in a
temperature- (22◦C) and light-controlled room and given free
access to food and water. At the time of experiment, mice were
8–12 weeks of age.
Mitochondrial Isolation
For mitochondrial isolation, mice were anesthetized by
inhalation of isoflurane following a 4 h fast and were euthanized
via double pneumothorax. Under anesthesia, liver, or hind
limb muscles (gastrocnemius, quadriceps, and biceps femoris)
were immediately excised and rinsed in ice-cold mitochondrial
isolation medium (MIM) containing: 300mM Sucrose, 10mM
HEPES, and 1mM EGTA. Tissues were then transferred to a dry
dish and minced continuously for 5min, then transferred to a
50ml tube containing 10ml of MIM. For skeletal muscle, trypsin
(100mg/ml) was added for exactly 2min, then soybean trypsin
inhibitor in 10ml of MIM + 1mg/ml BSA was added to halt the
reaction. Tissue was then gently mixed by inversion and allowed
to settle to the bottom of the tube. Supernatant was discarded and
tissue re-suspended in MIM+BSA (20ml/g tissue). Minced liver
was not treated with trypsin. Tissues were then homogenized
using a tight-fitting Teflon glass homogenizer (∼10 passes)
and centrifuged at 800 g for 10min at 4◦C. Supernatant was
transferred to Oakridge tubes and centrifuged at 8000 g for
15min at 4◦C. Supernatant was discarded and pellet was washed
and re-suspended in 10ml of MIM+BSA and centrifuged again
at 8000 g for 15min at 4◦C. The final pellet was re-suspended
in 50µl of MIM. Mitochondrial protein concentration was
determined by spectrophotometry using the bicinchoninic acid
method (Pierce). In some experiments, mitochondria were
fractured by three freeze-thaw cycles and directly assayed for
complex I specific activity (Barrientos et al., 2009).
Preparation of Mouse Permeabilized
Myofiber Bundles (PmFBs)
The PmFB technique used was partially adapted from previous
methods (Kuznetsov et al., 1996; Tonkonogi et al., 2003) and
has been described previously (Anderson and Neufer, 2006).
Mice were anesthetized by inhalation of isoflurane and the red
(RG) and white (WG) portions of the gastrocnemius muscle
were immediately excised. Muscle samples were placed in
ice-cold (4◦C) Buffer X containing (in mM): 7.23 K2EGTA,
2.77 CaK2EGTA, 20 Imidazole, 20 Taurine, 5.7 ATP, 14.3
Phosphocreatine, 6.56 MgCl2-6H2O, and 50 MES (pH 7.1,
295 mOsm). Under a dissecting microscope (Leica Optics),
fat, and connective tissue were removed and muscle samples
were separated into small bundles of fibers (<1mg wet
weight/fiber bundle). Fiber bundles were permeabilized in
Buffer X supplemented with 40µg/ml saponin, a mild,
cholesterol-specific detergent for 30min at 4◦C as previously
described (Anderson and Neufer, 2006). Since the sarcolemmal
membrane contains a large amount of cholesterol relative
to the mitochondrial membrane, this technique selectively
permeabilizes the sarcolemma while leaving mitochondrial
membranes and ultra-structure intact (Kuznetsov et al., 2008;
Picard et al., 2011). PmFBs were then washed in ice-cold Buffer
Z containing (in mM): 105 K-MES, 30 KCl, 5 KH2PO4, 5
MgCl2-6H2O, and 0.5mg/ml Bovine serum albumin (pH 7.1,
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295 mOsm) and remained in Buffer Z on a rotator at 4◦C until
analysis (<4 h).
Mitochondrial Camp Production Assay
Two different sets of experiments were done to measure
mitochondrial cAMP production in the current study. First,
isolated liver mitochondria were incubated for 10min at 37◦C
in 300µl of MAITE medium containing (in mM): 10 Tris-
HCl, 25 sucrose, 75 sorbitol, 100 KCl, 0.5 EDTA, 5 MgCl2, and
1mg/ml BSA; pH 7.4. MAITE medium was also supplemented
with 300mM HEPES to maintain pH in the presence of HCO−3
(Acin-Perez et al., 2009b) and 1mM ATP as substrate for
cAMP production. Experiments were performed under three
conditions: no additions, 30mM HCO−3 and HCO
−
3 plus 25µM
KH7, an inhibitor of sAC (Hess et al., 2005). Second, skeletal
muscle mitochondria (250µg/ml) were incubated at 37◦C in
300µl of MAITE medium supplemented with 1mM ATP,
10µg/ml oligomycin and in the presence or absence of 25µM
KH7 or 5µM acetazolamide (AZA), a carbonic anhydrase
inhibitor to prevent conversion of CO2 to HCO
−
3 (Maren, 1960).
Following an initial 10min acclimation period, mitochondria
were incubated for 5min in the presence of the following
respiratory substrate combinations: 5 pyruvate/2mM malate,
5mM succinate, or 25µM palmitoyl-L-carnitine/2mM malate.
A separate set of control samples did not receive respiratory
substrates. In some experiments, 1µM FCCP was added to
uncouple O2 consumption from ATP synthesis and thereby
accelerate TCA cycle flux. Reactions were halted by the addition
of 0.1M HCl, and then samples were flash frozen and stored in
liquid N2 until analysis for cAMP (Complete cAMP ELISA Kit,
Enzo Life Sciences).
Mitochondrial Bioenergetics Assays
Mitochondrial respiration experiments in both isolated
mitochondria and PmFBs were performed using a high-
resolution oxygraph (Oroboros O2k, Innsbruck Austria).
Respirometry experiments using isolated mitochondria were
performed in Buffer Z at 25◦C while substrate titration
experiments in PmFBs were performed at 37◦C in Buffer
Z supplemented with 20mM creatine monohydrate to
maximize phosphate transfer in PmFBs (Kuznetsov et al.,
1996). Blebbistatin (20µl) was also added during PmFB
experiments to mitigate the effects of contraction on respiratory
kinetics (Perry et al., 2011).
Mitochondrial H2O2 emitting potential, defined as the H2O2
that escapes the matrix, was measured via Amplex Ultra Red
(Invitrogen) fluorescence detected at 565/600 ex/em at 37◦C in
a monochromatic spectrofluorometer (Horiba Jobin-Yvon) with
Buffer Z as previously described (Anderson and Neufer, 2006).
Assays were performed in the presence of 25 U/ml superoxide
dismutase to ensure superoxide produced and released on
the outer surface of the mitochondrial inner membrane was
converted to H2O2. Mitochondrial H2O2 emitting potential in
PmFBs was measured during either reverse electron flow using
5mM succinate or forward electron flow using 5mM glutamate
and 2mMmalate followed by the addition of rotenone (Lambert
and Brand, 2004). Once steady-state rates of H2O2 emission
were established (< 10min), 1µM auranofin, a thioredoxin
reductase inhibitor, was added to remove oxidant scavenging as
a potentially confounding factor (Fisher-Wellman et al., 2013).
In addition to yielding a measure of H2O2 production, this
allowed for the determination of oxidant scavenging capacity as
the difference in H2O2 emission before and after the addition of
auranofin.
In experiments utilizing 8Br-cAMP or H89, compounds
were added to the oxygraph chamber or cuvette with isolated
mitochondria or PmFBs for 10min prior to any subsequent
additions.
Statistical Analyses
Comparisons between control and treatment groups were made
using One-way ANOVA with Student Newman-Keuls post-hoc
test where appropriate using Prism statistical software (GraphPad
Prism 6). Pair-wise comparisons were made using student’s
paired two-way t-test. In all experiments, data are reported as
mean ± SEM unless otherwise noted. Significance level was set
at p < 0.05.
RESULTS
TCA Cycle Flux Does Not Increase [cAMP]
in Isolated Mitochondria
The inner mitochondrial membrane is impermeable to cytosolic
cAMP (Di Benedetto et al., 2013) and, therefore, matrix cAMP
has been proposed to be generated locally by CO2-mediated
activation of sAC. Evidence in support of this hypothesis comes
from data showing that addition of exogenous HCO−3 induces a
small increase (∼10%) in mitochondrial cAMP that is prevented
by the sAC inhibitor KH7 (Chen et al., 2000; Litvin et al., 2003;
Zippin et al., 2003; Acin-Perez et al., 2009b; Di Benedetto et al.,
2013). In the present study, addition of HCO−3 to isolated liver
mitochondria generated a small but significant increase in cAMP
that, in contrast to previous findings (Acin-Perez et al., 2009b),
was not blunted by KH7 (Figure 1A).
The TCA cycle has been proposed as the source of CO2
needed to activate sAC in mitochondria (Acin-Perez et al.,
2009b), although this has yet to be demonstrated experimentally.
Using isolated mitochondria from skeletal muscle in the
presence of 1mM ATP, we were unable to detect any increase
in cAMP during respiration supported by CO2-generating
substrates (pyruvate/malate or palmitoyl-L-carnitine/malate)
compared with mitochondria in the absence of substrate
or those oxidizing non CO2-generating substrates (succinate)
(Figure 1B). Mitochondrial cAMP remained unchanged even
when TCA cycle flux was accelerated by the mitochondrial
uncoupler FCCP. Finally, consistent with the data from liver
mitochondria (Figure 1A), cAMP levels were not decreased by
the putative sAC inhibitor KH7 or acetazolamide (AZA), a
carbonic anhydrase inhibitor. These findings suggest that, at least
under the conditions tested, endogenous TCA cycle-derived CO2
production is not sufficient to increase mitochondrial cAMP in
skeletal muscle mitochondria.
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FIGURE 1 | TCA-cycle dependent flux does not increase mitochondrial cAMP. (A) cAMP was measured in isolated liver mitochondria in the presence of 1mM
ATP, and in the absence of inhibitors (white bar), the presence of 30mM HCO−3 (black bar) or the presence of both HCO
−
3 and 25µM KH7 (gray bar). N = 4/condition.
* denotes p < 0.05 compared to untreated condition. (B) cAMP was measured in isolated skeletal muscle mitochondria in the presence of 1mM ATP, and in the
absence (black bars) of respiratory substrates or in the presence of pyruvate/malate (white bars), succinate (light gray bars) or palmitoyl-L-carnitine/malate (dark gray
bars). For each round of experiments, a single mitochondrial preparation was used for all substrate conditions, including parallel experiments with FCCP, KH7, and
acetazolamide (AZA). N = 4 mitochondrial preparations from individual mice.
Regulation of OXPHOs Function by
Mitochondrial cAMP/PKA Signaling
The functional consequence of mitochondrial cAMP/PKA
signaling on OXPHOS function is unclear as exogenous
activation of PKA has been reported to either increase (Acin-
Perez et al., 2009b, 2011) or decrease (Di Benedetto et al., 2013)
mitochondrial ATP production. Here, a series of experiments
were performed to test the hypothesis that OXPHOS is regulated
by mitochondrial cAMP/PKA signaling.
First, rates of oxygen consumption (JO2) were measured
in isolated liver mitochondria in the absence or presence of
1mM 8Br-cAMP, a membrane-permeable cAMP mimetic
(Figure 2A). Surprisingly, 8Br-cAMP did not alter basal
or maximal ADP-stimulated glutamate/malate-supported
respiration. Similar to previous findings (Acin-Perez et al.,
2009b), KH7 nearly completely inhibited ADP-stimulated
respiration. Curiously however, the effect was not reversed or
attenuated by the addition of 8Br-cAMP, which should bypass
the inhibition of sAC. Addition of cytochrome c or FCCP also
failed to restore respiration in the presence of KH7. Together,
these findings suggest that the inhibitory effect of KH7 occurs
independent of sAC/cAMP/PKA signaling and is not associated
with loss of mitochondrial membrane integrity.
To further define the mechanism by which KH7 acts
independently of cAMP signaling (Tian et al., 2011; Di Benedetto
et al., 2013), complex I activity was measured in freeze-fractured
fragments of isolated skeletal muscle mitochondria in the absence
or presence of KH7. Addition of KH7 led to an immediate
ablation of complex I activity that was not recovered by the
addition of 8Br-cAMP (Figure 2B). Dose-response curves for
complex I activity as a function of KH7 concentration in PKA-
depleted mitochondrial fragments revealed an IC50 value of
3.7µM (Figure 2C), comparable to previously reported IC50
values of KH7 for sAC (Hess et al., 2005; Bitterman et al., 2013).
These findings suggest that the effects of KH7 on mitochondrial
respiration are mediated by direct inhibition of complex I.
Besides KH7, the only other known sAC inhibitor with
an IC50 below 10µM is the naturally occurring estrogen
metabolite 2-hydroxyestradiol (2-HE) (Steegborn et al., 2005).
Anecdotal reports have suggested that 2-HE is also capable of
generating oxidant species via redox cycling (Fussell et al., 2011),
although this has not been demonstrated experimentally. Using
a cell/organelle-free based H2O2 detection system, we found
that 2-HE, but not its metabolite 2-methoxyestradiol (2-ME),
generates H2O2 spontaneously (Figure 3A) in a dose-dependent
(Figure 3B) and catalase-sensitive (Figure 3C) manner. H2O2
production was detected with as little as 200 nM 2-HE, a
concentration more than 50-fold lower than has been previously
used to inhibit sAC in cell-based assays (Tian et al., 2011; Di
Benedetto et al., 2013). These findings raise significant concerns
regarding the specificity and use of both KH7 and 2-HE as tools
to study cAMP-related signaling events.
Inhibition of PKA Decreases Complex
I-supported Respiratory Capacity
To further explore the potential impact of kinase activity on
mitochondrial function, we focused our attention on PKA.
Incubation of HeLa cells for 30min with 1µM H89, a
PKA inhibitor (Chijiwa et al., 1990), has been shown to
decrease mitochondrial respiratory capacity (Acin-Perez et al.,
2009b), but the specific site(s) of regulation remains unknown.
Using mitochondria isolated from liver, H89 dose-dependently
decreased ADP-stimulated respiration supported by complex I
(Figure 4A), but not complex II (Figure 4B) substrates. These
findings prompted us to specifically focus on the role of PKA in
the regulation of complex I activity.
H89-mediated PKA Inhibition Alters
ADP-supported Respiratory Kinetics
To further define the impact of PKA inhibition on complex
I-supported respiration, ADP titration experiments were
performed on H89-treated PmFBs during respiration supported
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FIGURE 2 | The soluble adenylyl cyclase inhibitor KH7 inhibits complex
I activity independent of cAMP/PKA signaling. (A) JO2 was measured
during a step-wise titration protocol in isolated liver mitochondria in the
absence (white bars) or presence (gray bars) of 1mM 8Br-cAMP. Each
sequential addition was made after reaching a steady-state rate of O2 flux.
N = 4/condition. (B) Complex I activity was determined by the oxidation rate
of NADH in fragments of isolated skeletal muscle mitochondria following
no treatment (dashed line) or sequential addition of 25µM KH7 and 100µM
8Br-cAMP (solid line). (C) Dose-response inhibition curve generated for
inhibition of complex I activity as a function of KH7 concentration. N = 3
separate observations.
by pyruvate/malate. Both slow-twitch (RG) and fast-twitch
(WG) PmFBs were used for these studies because the metabolic
phenotype (e.g., oxidative vs. glycolytic) of the muscle governs
both respiratory kinetics (Kuznetsov et al., 1996) and H2O2
emitting potential (Anderson and Neufer, 2006). Initial
examinations revealed a decrease in respiration at and above
an ADP concentration of 75µM in RG (Figure 5A) and
200µM in WG (Figure 5B). Applying Michaelis Menten-like
kinetic analyses, these data were further dissected to yield
maximal respiratory capacity (Vmax) and sensitivity to ADP
(apparent Km—the ADP concentration required to elicit 50%
of Vmax) (Kuznetsov et al., 1996). H89 treatment decreased
both the apparent Km and Vmax in RG (Figure 5C) and
WG (Figure 5D), indicating an increased sensitivity to ADP
FIGURE 3 | The soluble adenylyl cyclase inhibitor 2-hydroxyestradiol
(2-HE) produces H2O2 in a cell-free system. (A) Comparison of H2O2
production from 2-methoxyestradiol (2-ME) and 2-hydroxyestradiol (2-HE). (B)
Dose-dependent rate of H2O2 production of 2-HE over a 5-min span. Results
in (A,B) are the product of N=3 separate experiments. (C) H2O2 production
by 200 nM 2-HE in the absence (solid line) or presence (dashed line) of 100
U/ml catalase.
but decreased maximal respiratory capacity. H89 treatment
decreased non-ADP stimulated respiration in RG with a similar,
but non-significant (p = 0.08), trend in WG (Figure 5E).
Finally, H89 treatment decreased respiratory control ratio
(RCR), an index of mitochondrial coupling, in both RG and WG
(Figure 5F). Altogether, these data suggest that inhibition of PKA
decreases respiration supported by complex I, but not complex
II, and does so during both proton leak- and ADP-dependent
respiration.
H89-mediated PKA Inhibition Alters
Complex I Substrate Kinetics
To further explore the possibility that PKA regulates complex
I, pyruvate and glutamate titrations were performed under
ADP-stimulated conditions in RG and WG PmFBs in the
absence or presence of H89. In both RG (Figure 6A) and WG
(Figure 6B), inhibition of PKA decreased respiration at or above
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FIGURE 4 | PKA regulates Complex I- but not Complex II-supported respiration in isolated liver mitochondria. JO2 was measured with complex I (A) or
complex II (B) supported substrates in the absence (white bars) or presence of 1 (black bars), 5 (dark gray bars), or 10 (light gray bars) µM H89. N = 4–6/condition.
* denotes p < 0.05 compared to control.
FIGURE 5 | PKA regulates ADP kinetics, proton leak and respiratory control ratio in oxidative and glycolytic mouse PmFBs. ADP titration experiments
were performed in RG (A) and WG (B) PmFBs with pyruvate and malate in the absence (open symbol) or presence (closed symbol) of 10µM H89 in the assay media.
Michaelis Menten-like kinetics generated from ADP titration experiments in RG (C) and WG (D). (E) Non-ADP stimulated JO2 was compared from ADP titration
experiments in the absence (white bars) or presence (gray bars) of 10µM H89 in RG (left) and WG (right). (F) Respiratory control ratio (ADP-stimulated JO2/non-ADP
stimulated JO2) was calculated from ADP titration experiments in the absence (white bars) or presence (gray bars) of 10µM H89 in RG (left) and WG (right). N =
4–6/condition. * denotes p < 0.05 compared to Control.
a pyruvate concentration of 100µM.This was accompanied by an
increase in sensitivity to pyruvate and a decrease in respiratory
capacity in both tissues (Figures 6C,D). Glutamate titration
experiments yielded similar data (Figures 6E–H). These findings
using two distinct NADH-linked substrates provide evidence that
PKA-mediated phosphorylation influences complex I-supported
respiratory kinetics.
H89-mediated PKA Inhibition Decreases
H2O2 Production during Reverse Electron
Flow
With evidence suggesting a role for PKA in the regulation of
respiratory kinetics, particularly at complex I, we next sought
to examine whether PKA affects the susceptibility of complex I
to electron leak and H2O2 production/emission during reverse
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FIGURE 6 | Effects of PKA inhibition on substrate oxidation kinetics in mouse PmFBs. Pyruvate titrations were performed in PmFBs from RG (A) and
WG (B) in the absence (open symbol) or presence (closed symbol) of 10µM H89 in the assay media. Km and Vmax were determined based on
Michaelis-Menten like kinetics in RG (C) and WG (D). N = 4–8/condition. * denotes p < 0.05 compared to Control. Glutamate titrations were performed in RG
(E) and WG (F) in the absence (open symbol) or presence (closed symbol) of 10µM H89. Km and Vmax were determined based on Michaelis-Menten like
kinetics in RG (G) and WG (H). N = 4–8/condition. * denotes p < 0.05 compared to Control.
(i.e., succinate) or forward (glutamate/malate/rotenone) electron
flow. In PmFBs from both RG (Figure 7A) andWG (Figure 7B),
inhibition of PKA decreased H2O2 emission during reverse, but
not forward, electron flow. Addition of auranofin to inhibit
mitochondrial H2O2 scavenging elicited similar increases in
H2O2 emission in the absence or presence of H89. Total
mitochondrial oxidant scavenging was also not affected by H89.
Together these data indicate that PKA inhibition affects H2O2
production, not scavenging, and that PKAmaymediate its effects
on mitochondrial energetics, at least in part, via regulation of
electron flow at or near the interface between complex I and the
Q-pool.
DISCUSSION
In recent years, starting with the discovery of sAC (Buck et al.,
1999), a potential role for cAMP signaling in the mitochondrial
matrix has emerged (Valsecchi et al., 2013). Several reports
have described a role for sAC within mitochondria (Zippin
et al., 2003; Acin-Perez et al., 2009b; Di Benedetto et al.,
2013), the existence of mitochondrial cAMP/PKA signaling
microenvironments (Papa et al., 1999; Livigni et al., 2006; Di
Benedetto et al., 2008; Acin-Perez et al., 2011), and a wide variety
of reversibly phosphorylated mitochondrial proteins (Zhao et al.,
2011; Grimsrud et al., 2012). In contrast with plasma membrane-
bound G-protein-linked forms of AC, sAC is activated by
bicarbonate and calcium (Litvin et al., 2003). CO2 produced
by the TCA cycle, and subsequent conversion to HCO−3 by
carbonic anhydrase, has been suggested as a mechanism by which
sAC/PKA signaling is activated in mitochondria (Acin-Perez
et al., 2009b). In the present study however, evidence is provided
that mitochondrial cAMP/PKA signaling is not activated by
increased flux through the TCA cycle. In addition, two widely
used inhibitors of sAC were found to have distinct non-specific
effects that limit their utility in studies of mitochondrial function.
Notably however, pharmacological inhibition of PKA was found
to alter OXPHOS kinetics during respiration supported by
NADH-linked substrates and H2O2 emission during reverse
electron flow through complex I, providing additional evidence
that complex I may be regulated by reversible phosphorylation.
The discovery and subsequent characterization of sAC
within specific cellular organelles has led to the concept of
compartmentalized cAMP signaling. A seminal finding in this
field was that exogenous HCO−3 can increase cAMP levels via
activation of sAC (Chen et al., 2000), a discovery that has
been confirmed in multiple subsequent studies (Litvin et al.,
2003; Zippin et al., 2003; Di Benedetto et al., 2013), including
this report (Figure 1A). A central premise of the sAC-cAMP-
PKA axis is that endogenous HCO−3 generated during increased
flux through the TCA cycle is responsible for activating sAC.
Here we directly tested this hypothesis and found that even
during maximal uncoupled respiration, and in the presence of
multiple substrate combinations that feed into the TCA cycle,
mitochondrial cAMP levels did not change (Figure 1B). ATP
was included in the assay at a concentration (1mM) sufficient to
provide substrate for sAC without inducing substrate inhibition
(>5mM) (Litvin et al., 2003). These findings therefore suggest
that endogenous production of CO2 from the TCA cycle does
not activate sAC in skeletal muscle mitochondria. More recent
findings have provided evidence that an increase in the frequency
and amplitude of matrix Ca2+ oscillations, as would occur
during muscle contractions, is likely the more physiologically
important regulator of sAC in mitochondria (Di Benedetto et al.,
2013).
Defining the role of sAC in the regulation of mitochondrial
bioenergetics has also hinged greatly on the use of two
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FIGURE 7 | PKA signaling regulates reverse, but not forward electron flow, through complex I in mouse PmFBs. Mitochondrial H2O2 emitting potential
(mOEP) was measured in RG (A) and WG (B) with succinate (left) or glutamate/malate/rotenone (right) and in the absence (white bars) or presence (gray bars) of
10µM H89 in the assay media. Auranofin (1µM) was added to specifically measure H2O2 production, and an “oxidant scavenging index” was determined based on
the increase in mOEP following addition of auranofin. N = 4–8/condition. * denotes p < 0.05 compared to Control.
compounds marketed as sAC inhibitors: KH7 (Hess et al., 2005;
Acin-Perez et al., 2009a,b, 2010) and 2-HE (Steegborn et al.,
2005; Tian et al., 2011; Di Benedetto et al., 2013). In this report,
we provide evidence demonstrating that both KH7 and 2-HE
have distinct non-specific effects that preclude their use for
studying mitochondrial energetics. First, KH7 directly inhibits
mitochondrial respiration independent of cAMP/PKA signaling
(Figure 2A) (Di Benedetto et al., 2013), and it appears to do so via
direct inhibition of complex I (Figures 2B,C). Second, 2-HE, a
naturally occurring estrogenmetabolite, spontaneously generates
high rates of H2O2 (Figures 3A–C), potentially affecting redox
buffering systems and thus the oxidation state of mitochondrial
proteins. Previous studies (Hess et al., 2005; Steegborn et al., 2005;
Acin-Perez et al., 2009a,b, 2010; Tian et al., 2011; Di Benedetto
et al., 2013) using one or both of these compounds to examine the
link between cAMP/PKA signaling and mitochondrial function
should therefore be interpreted with caution. The recently
elucidated crystal structure of human sAC during catalysis
and activation via HCO−3 (Kleinboelting et al., 2014) will
hopefully facilitate the development of sAC inhibitors with
greater specificity.
The impact of membrane permeable cAMP analogs on
mitochondrial bioenergetics has also produced conflicting
data. In both intact cells and isolated mitochondria, Acin-
Perez et al. (2009b) found that 8Br-cAMP induced a slight
but statistically significant increase in respiration under
both basal and maximally-stimulated respiration conditions.
ATP synthesis rate and mitochondrial membrane potential
under non-phosphorylating conditions were also increased
by 8Br-cAMP (Acin-Perez et al., 2009b). Di Benedetto
et al. (2013) however failed to observe any impact of
8Br-cAMP, or several other more permeable analogs, on
mitochondrial ATP concentration in intact cells. In the
present study, 8Br-cAMP also failed to increase either basal
or ADP-stimulated respiration in isolated liver mitochondria
(Figure 2A).
However, the notion that a mitochondrial matrix sAC-
cAMP-PKA axis regulates OXPHOS is supported by multiple
lines of direct and indirect evidence (Raha et al., 2002; Acin-
Perez et al., 2009b; Valenti et al., 2011; Di Benedetto et al.,
2013), including the recent finding that numerous electron
transport proteins in mouse liver and skeletal muscle originally
identified in the MitoCarta (Pagliarini et al., 2008) have PKA
consensus phosphorylation sites (Zhao et al., 2011; Grimsrud
et al., 2012). Using cAMP-specific FRET sensors, two groups (Di
Benedetto et al., 2013; Lefkimmiatis et al., 2013) have recently
provided the most direct evidence that cAMP is produced inside
mitochondria by sAC in response to increased matrix Ca2+ and,
to a lesser extent, HCO−3 . Additionally, literature spanning over
20 years implicates complex I as a target of PKA-dependent
phosphorylation (Technikova-Dobrova et al., 1993; Sardanelli
et al., 1995; Papa et al., 1999). In the current study, PKA inhibition
was found to dose-dependently decrease complex I, but not
complex II, supported respiration (Figures 4A,B), thus providing
further direct evidence that PKA-mediated phosphorylation
plays an important role in the regulation of complex I activity.
In PmFBs, H89-mediated inhibition of PKA elicited effects
on mitochondrial respiratory kinetics, respiratory capacity, and
oxidant emission that converged on complex I. Increased
sensitivity of OXPHOS to both ADP (Figures 5C,D) and
complex I-supported respiratory substrates (Figures 6C,D,G,H),
combined with decreased maximal respiratory capacity, suggest
a “bottleneck” in the ETS established by PKA inhibition.
The effects of PKA inhibition were qualitatively similar in
PmFBs from predominantly red oxidative and white glycolytic
muscles, suggesting the mitochondrial phospho-regulatory
mechanisms are similar in the two fiber types. To elucidate
how PKA may regulate complex I-mediated electron flow,
two substrate/inhibitor combinations were used to examine
forward or reverse electron flow. The flavin (F) site of complex
I is responsible for NADH reduction and the majority of
electron leak from forward electron flow (Treberg et al., 2011).
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H2O2 emitting potential at this site was not affected by H89
(Figures 7A,B). The quinone (Q) site of complex I is responsible
for donating electrons to the Q pool and accounts for the
majority of electron leak that can occur from reverse electron
flow during respiration supported by the complex II substrate
succinate. Inhibition of PKA decreased electron leak from the
Q-site during reverse electron flow but not from the F-site
during forward electron flow (Figures 7A,B), suggesting that
PKA regulates complex I activity somewhere between these two
sites of electron transfer. This is of particular interest because
the nuclear-encoded 18 kDa subunit of complex I physically
lies in between these two sites of electron transfer, is exposed
to the mitochondrial matrix (Baradaran et al., 2013), and is a
physiologically relevant site of PKA-mediated phosphorylation
(Sardanelli et al., 1995; Papa et al., 1999; Papa, 2002). Loss of
the gene that encodes this subunit (NDUFS4) in mice replicates
Leigh syndrome (Quintana et al., 2010; Johnson et al., 2013), a
devastating human neurological, mitochondrial-linked disease.
Although the NDUFS4 subunit is not thought to be directly
involved in electron transfer, it is possible that PKA-mediated
phosphorylation within this subunit alters electron transfer
and/or (Lochner and Moolman, 2006) complex I function in a
currently undefined manner.
The finding that PKA inhibition lowered mitochondrial
JH2O2 emission in PmFBs is intriguing, as it suggests that
activation of PKA signaling may accelerate mitochondrial JH2O2
emission. However, in the present studies, addition of 8Br-
cAMP to activate PKA signaling failed to alter ADP-stimulated
respiratory capacity, and accelerating TCA cycle flux failed
to enhance cAMP levels. Along these same lines, calcium
has recently been shown to enhance the driving forces of
the oxidative phosphorylation system, although the effect is
seen only when calcium is depleted from mitochodria prior
to calcium stimulation (Glancy et al., 2013). Together, these
findings were interpreted to suggest that calcium, and potentially
PKA signaling, may be already relatively high/active in isolated
mitochondria, and thus experiments to further activate PKA
signaling were not pursued.
A caveat to experiments using H89 is that this drug is not
entirely specific for PKA (Davies et al., 2000; Lochner and
Moolman, 2006). However, the data provided are in agreement
with previous reports demonstrating a role for PKA in the
regulation of complex I in other tissues (Sardanelli et al., 1995;
Papa et al., 1999; Papa, 2002). In the present study, H89 was
chosen because a primary objective of this project was to compare
findings in muscle PmFBs to previous findings in isolated
liver mitochondria (Acin-Perez et al., 2009a,b; 2010; 2011).
Interestingly, a recent report in isolated rat liver mitochondria
suggests that hydrogen sulfide (H2S) is capable of regulating
mitochondrial respiration (Módis et al., 2013), possibly via
inhibition of phosphodiesterase 2A (PDE2A), a mitochondrial
PDE isoform (Acin-Perez et al., 2011). Furthermore, in this
report (Módis et al., 2013), the authors found that the
inhibitory cAMP analog Rp-cAMP decreased complex II-
supported respiration, although complex I-supported respiration
was not reported. It remains to be seen whether PKA-mediated
regulation of skeletal muscle complex I activity occurs with
alternative PKA inhibitors like Rp-cAMP.
In conclusion, this report provides a novel collection of
studies that: (1) challenge the notion that mitochondrial cAMP
is regulated by TCA cycle flux, (2) reveal significant non-
specific effects of widely used sAC inhibitors, and (3) provide
the first functional evidence of PKA regulation of complex I
in mouse muscle and liver mitochondria. These findings are
of physiological significance particularly because they suggest
that cAMP/PKA signaling not only regulates mitochondrial
respiration, but also oxidant production. There is promise in
the possibility that the mitochondrial cAMP/PKA axis can be
manipulated to improve skeletal muscle metabolic health. Future
studies await the development of targeted genetic approaches
to more mechanistically examine the physiological role of
mitochondrial cAMP-PKA signaling in health and disease.
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